A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
The efficacy and safety of risperidone long acting injectable (LAI) for preventing recurrence of mood episodes in patient with bipolar| disorder was evaluated in a randomized, placebocontrolled study. After a 12 week pen label period with risperidone LAI (n=560), patient who did not experience a rec...
Saved in:
Main Authors: | , , , , , , |
---|---|
格式: | Article |
語言: | English |
出版: |
Elsevier
2012
|
主題: | |
在線閱讀: | http://eprints.um.edu.my/9627/1/00000797_93580.pdf http://eprints.um.edu.my/9627/ |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Universiti Malaya |
語言: | English |